Comment on:"Ketamine vs haloperidol for prevention of cognitive dysfunction and postoperative delirium: A phase IV multicentre randomised placebo-controlled double-blind clinical trial"

被引：0
|
作者：
Liu, Jing [1 ]
Yu, Dongdong [1 ]
Li, Jianli [1 ]
机构：
[1] Hebei Gen Hosp, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ANESTHESIA | 2022年 / 77卷
关键词：
D O I：
10.1016/j.jclinane.2021.110634
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Furst, Daniel E.
    Goldin, Jonathan
    Kim, Grace
    Kuwana, Masataka
    Allanore, Yannick
    Matucci-Cerinic, Marco
    Distler, Oliver
    Shima, Yoshihito
    van Laar, Jacob M.
    Spotswood, Helen
    Wagner, Bridget
    Siegel, Jeffrey
    Jahreis, Angelika
    Denton, Christopher P.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 963 - 974
  • [42] Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial
    Su, Xian
    Meng, Zhao-Ting
    Wu, Xin-Hai
    Cui, Fan
    Li, Hong-Liang
    Wang, Dong-Xin
    Zhu, Xi
    Zhu, Sai-Nan
    Maze, Mervyn
    Ma, Daqing
    LANCET, 2016, 388 (10054): : 1893 - 1902
  • [43] The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
    Davey, Christopher G.
    Chanen, Andrew M.
    Hetrick, Sarah E.
    Cotton, Sue M.
    Ratheesh, Aswin
    Amminger, Guenter P.
    Koutsogiannis, John
    Phelan, Mark
    Mullen, Edward
    Harrison, Ben J.
    Rice, Simon
    Parker, Alexendra G.
    Dean, Olivia M.
    Weller, Amber
    Kerr, Melissa
    Quinn, Amelia L.
    Catania, Lisa
    Kazantzis, Nikolaos
    McGarry, Patrick D.
    Berk, Michael
    LANCET PSYCHIATRY, 2019, 6 (09): : 735 - 744
  • [44] Topical Dorzolamide for Macular Holes: A Randomised, Double-Blind, Placebo-Controlled Trial-Comment
    Abihaidar, Nicolas
    Bouheraoua, Nacim
    Borderie, Vincent
    Garcin, Thibaud
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2025,
  • [45] IV APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial
    Kranke, P.
    Eberhart, L.
    Motsch, J.
    Chassard, D.
    Wallenborn, J.
    Diemunsch, P.
    Liu, N.
    Keh, D.
    Bouaziz, H.
    Bergis, M.
    Fox, G.
    Gan, T. J.
    BRITISH JOURNAL OF ANAESTHESIA, 2013, 111 (06) : 938 - 945
  • [46] Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
    Alain Jacquet
    Pierre-Olivier Girodet
    Antoine Pariente
    Karelle Forest
    Laurent Mallet
    Nicholas Moore
    Arthritis Research & Therapy, 11
  • [47] Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
    Jacquet, Alain
    Girodet, Pierre-Olivier
    Pariente, Antoine
    Forest, Karelle
    Mallet, Laurent
    Moore, Nicholas
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)
  • [48] Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
    Paton, Nicholas I.
    Lee, Lawrence
    Xu, Ying
    Ooi, Eng Eong
    Cheung, Yin Bun
    Archuleta, Sophia
    Wong, Gerard
    Wilder-Smith, Annelies
    LANCET INFECTIOUS DISEASES, 2011, 11 (09): : 677 - 683
  • [49] Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial
    Wittert, Gary
    Atlantis, Evan
    Grossmann, Mathis
    Yeap, Bu B.
    Conway, Ann
    Stuckey, Bronwyn
    Handelsman, David
    McLachlan, Robert
    Allan, Carolyn
    Jenkins, Alicia
    Daniel, Mark
    Bracken, Karen
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 47 - 48
  • [50] Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study*
    Al-Qadheeb, Nada S.
    Skrobik, Yoanna
    Schumaker, Greg
    Pacheco, Manuel N.
    Roberts, Russel J.
    Ruthazer, Robin R.
    Devlin, John W.
    CRITICAL CARE MEDICINE, 2016, 44 (03) : 583 - 591
12345